help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Badolato, R.
Right arrow Articles by Tenore, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Badolato, R.
Right arrow Articles by Tenore, A.

Journal of Clinical Endocrinology & Metabolism, Vol 79, 984-990, Copyright © 1994 by Endocrine Society


ARTICLES

Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry

R Badolato, HM Bond, G Valerio, A Petrella, G Morrone, MJ Waters, S Venuta and A Tenore
Department of Pediatrics, University of Naples Federico II School of Medicine, Italy.

Although several reports indicate proliferative and functional effects of human GH (hGH) on peripheral blood lymphocytes (PBL), no information is available about hGH receptor (GHR) expression in PBL subsets. Here, the surface membrane GHR levels were investigated in different human PBL subpopulations using a fluorescein isothiocyanate (FITC)-conjugated monoclonal antibody specific for the GHR (mAb263) in dual fluorochrome flow cytometric assays. Strong GHR expression was found in B-cells (CD20+), whereas CD2+ lymphocytes, including T-cells as well as natural killer cells, exhibited considerably lower levels of receptor expression. Similarly, using FITC-labeled recombinant hGH, receptor expression on CD20+ cells was significantly higher than that on CD2+ cells. Abundant expression of GHR in B-lymphocytes was confirmed by reverse transcriptase-polymerase chain reaction analysis of GHR messenger ribonucleic acid from isolated B-cells. Accordingly, the B- cell merits greater consideration as a GH target cell. The use of FITC- labeled mAb263 and hGH is of potential use for the study of GHR levels in patients exhibiting different types of growth disorders. Because of its high specificity for GHR, FITC-labeled mAb263 is also of considerable value for specifically demonstrating the presence of GHR, because hGH may interact with and act through PRL receptor, as shown previously in human neutrophils.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. L. Barclay, S. T. Anderson, M. J. Waters, and J. D. Curlewis
Regulation of Suppressor of Cytokine Signaling 3 (SOC3) by Growth Hormone in Pro-B Cells
Mol. Endocrinol., October 1, 2007; 21(10): 2503 - 2515.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Yoshizato, M. Tanaka, N. Nakai, N. Nakao, and K. Nakashima
Growth Hormone (GH)-Stimulated Insulin-Like Growth Factor I Gene Expression Is Mediated by a Tyrosine Phosphorylation Pathway Depending on C-Terminal Region of Human GH Receptor in Human GH Receptor-Expressing Ba/F3 Cells
Endocrinology, January 1, 2004; 145(1): 214 - 220.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. A. Hall, A. Bartke, and J. M. Martinko
Humoral Immune Response in Mice Over-expressing or Deficient in Growth Hormone
Experimental Biology and Medicine, July 1, 2002; 227(7): 535 - 544.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Hattori, T. Saito, T. Yagyu, B.-H. Jiang, K. Kitagawa, and C. Inagaki
GH, GH Receptor, GH Secretagogue Receptor, and Ghrelin Expression in Human T Cells, B Cells, and Neutrophils
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4284 - 4291.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
S. Recher, M. Raccurt, A. Lambert, P. E. Lobie, H. C. Mertani, and G. Morel
Prenatal and Adult Growth Hormone Gene Expression in Rat Lymphoid Organs
J. Histochem. Cytochem., March 1, 2001; 49(3): 347 - 354.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
K. Dorshkind and N. D. Horseman
The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency
Endocr. Rev., June 1, 2000; 21(3): 292 - 312.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J.-L. Bresson, S. Jeay, M.-C. Gagnerault, C. Kayser, N. Beressi, Z. Wu, S. Kinet, M. Dardenne, and M.-C. Postel-Vinay
Growth Hormone (GH) and Prolactin Receptors in Human Peripheral Blood Mononuclear Cells: Relation with Age and GH-Binding Protein
Endocrinology, July 1, 1999; 140(7): 3203 - 3209.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. Kooijman, A. Malur, S. C. van Buul-Offers, and E. L. Hooghe-Peters
Growth Hormone Expression in Murine Bone Marrow Cells Is Independent of the Pituitary Transcription Factor Pit-1
Endocrinology, September 1, 1997; 138(9): 3949 - 3955.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. Clark
The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function
Endocr. Rev., April 1, 1997; 18(2): 157 - 179.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society